These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 748017)

  • 1. Androgenic, antiandrogenic, and synandrogenic actions of progestins: role of steric and allosteric interactions with androgen receptors.
    Bullock LP; Bardin CW; Sherman MR
    Endocrinology; 1978 Nov; 103(5):1768-82. PubMed ID: 748017
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgenic, synandrogenic, and antiandrogenic actions of progestins.
    Bullock LP; Bardin CW
    Ann N Y Acad Sci; 1977 Mar; 286():321-30. PubMed ID: 281183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo metabolism and binding of 6 alpha-methylprogesterone; a progestin with anti-androgenic and synandrogenic activities.
    Brown TR; Bullock LP; Bardin CW
    Adv Exp Med Biol; 1979; 117():269-80. PubMed ID: 474281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
    Lemus AE; Enríquez J; García GA; Grillasca I; Pérez-Palacios G
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):121-9. PubMed ID: 9182866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of aging on androgen dynamics in the male rat.
    Robinette CL; Mawhinney MG
    Arch Biochem Biophys; 1978 Dec; 191(2):503-16. PubMed ID: 742886
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo binding of progestins to the androgen receptor of mouse kidney: correlation with biological activities.
    Brown TR; Bullock L; Bardin CW
    Endocrinology; 1979 Dec; 105(6):1281-87. PubMed ID: 499072
    [No Abstract]   [Full Text] [Related]  

  • 7. Synandrogenic and antiandrogenic effect of progestins: comparison with nonprogestational antiandrogens.
    Mowszowicz I; Bieber DE; Chung KW; Bullock LP; Bardin CW
    Endocrinology; 1974 Dec; 95(6):1589-99. PubMed ID: 4373227
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors regulating the androgenic action of progestins in mouse kidney.
    Bullock LP; Bardin CW
    Adv Exp Med Biol; 1979; 117():281-95. PubMed ID: 474282
    [No Abstract]   [Full Text] [Related]  

  • 9. Progestins can mimic, inhibit and potentiate the actions of androgens.
    Bardin CW; Brown T; Isomaa VV; Jänne OA
    Pharmacol Ther; 1983; 23(3):443-59. PubMed ID: 6371845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the binding of androgens to the cytosol proteins and nuclei of the rat seminal vesicle.
    Tóth M; Zakár T
    Acta Biochim Biophys Acad Sci Hung; 1977; 12(1):1-14. PubMed ID: 868463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of progestins on submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and antiandrogenic actions.
    Bullock LP; Barthe PL; Mowszowicz I; Orth DN; Bardin CW
    Endocrinology; 1975 Jul; 97(1):189-95. PubMed ID: 1140168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgenic regulation of ornithine decarboxylase activity in mouse kidney and its relationship to changes in cytosol and nuclear androgen receptor concentrations.
    Pajunen AE; Isomaa VV; Jänne OA; Bardin CW
    J Biol Chem; 1982 Jul; 257(14):8190-8. PubMed ID: 7085664
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of different forms of the androgen receptor.
    Lea OA; Wilson EM; French FS
    Endocrinology; 1979 Dec; 105(6):1350-60. PubMed ID: 499078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The requirement of cytoplasmatic receptors for entry of testosterone into nuclei of rat skeletal muscle.
    Bicíková M; Hampl R; Stárka L
    Endocrinol Exp; 1977 Dec; 11(4):271-5. PubMed ID: 305347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
    Stárka L; Hampl R; Kasal A; Kohout L
    J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different binding of testosterone, 19-nortestosterone and their 5 alpha-reduced derivatives to the androgen receptor of the rat seminal vesicle: a step toward the understanding of the anabolic action of nortesterone.
    Tóth M; Zakár T
    Endokrinologie; 1982 Oct; 80(2):163-72. PubMed ID: 7160340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
    Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
    Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgenic action of progestins and possible synandrogenic properties of antiandrogens used in oral contraceptives.
    Spona J
    Gynecol Obstet Invest; 1984; 17(2):66-72. PubMed ID: 6706245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol.
    Vigersky RA; Mozingo D; Eil C; Purohit V; Bruton J
    Endocrinology; 1982 Jan; 110(1):214-9. PubMed ID: 7053985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroids with modified ring A or B: screening for potential antiandrogenic and synandrogenic activity.
    Stárka L; Hampl R; Bicíková M; Cerný V; Fajkos J; Kasal A; Kocovský P; Kohout L; Velgová H
    J Steroid Biochem; 1980 Apr; 13(4):455-60. PubMed ID: 7190203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.